C. Licata

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.

C. Olson, D. Meaney-Delman, T. Oduyebo, 2021, The New England journal of medicine.

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

C. Olson, D. Meaney-Delman, T. Oduyebo, 2021, The New England journal of medicine.

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021

D. Shay, T. Clark, T. Shimabukuro, 2021, MMWR. Morbidity and mortality weekly report.

Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines.

W. Yih, Joshua T. B. Williams, M. Daley, 2022, Pediatrics.

First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

M. Sotir, T. Clark, T. Shimabukuro, 2021, MMWR. Morbidity and mortality weekly report.

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021

D. Shay, T. Shimabukuro, J. Baggs, 2021, MMWR. Morbidity and mortality weekly report.

The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response

C. Olson, T. Shimabukuro, J. Gee, 2023, Vaccine.

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system

D. Shay, T. Shimabukuro, J. Baggs, 2021, Vaccine.